Keyphrases
Myeloma Cells
100%
Bortezomib
100%
Cell Population
100%
Glucose-regulated Protein 78 (GRP78)
33%
Quiescence
26%
Induced Apoptosis
20%
Surviving Cells
20%
5-azacytidine
20%
Multiple Myeloma
13%
Unfolded Protein Response
13%
H2B-GFP
13%
Label Retention
13%
Survival Signaling
6%
Statistical Analysis
6%
Disease Progression
6%
Patient Samples
6%
CD138
6%
Cyclin-dependent Kinase 6 (CDK6)
6%
Progressive Disease
6%
In Vivo Experiment
6%
Cell Signaling
6%
T-test
6%
Growth Arrest
6%
P21Cip1
6%
Ki-67
6%
Mann-Whitney Test
6%
Cell Surface Display
6%
Survival Factor
6%
Chaperone
6%
Multiple Myeloma Patients
6%
Biochemical Tools
6%
Quiescent Cells
6%
Slow-cycling
6%
Demethylating Agents
6%
Bacterial Toxins
6%
Biochemistry, Genetics and Molecular Biology
Azacitidine
100%
Unfolded Protein Response
66%
Upregulation
33%
Low Drug Dose
33%
Downregulation
33%
Mann-Whitney U Test
33%
Survival Factor
33%
Demethylating Agent
33%
Immunology and Microbiology
Multiple Myeloma
100%
Myeloma Cell
100%
Cell Subpopulation
100%
Unfolded Protein Response
15%
Upregulation
7%
Downregulation
7%
Low Drug Dose
7%
Survival Factor
7%
Neuroscience
Bortezomib
100%
Azacitidine
20%
In Vitro
13%
In Vivo
13%
Unfolded Protein Response
13%
Chaperone
6%
Growth Disorder
6%
Bacterial Toxin
6%